-
Trump invites Putin to G20 summit in Miami
-
Grief and pain flow at hearing for Canadian suicide poison vendor
-
Archaelogical 'breakthrough' could confirm origins of Paris
-
Ireland boss Hallgrimsson says timing of Israel remarks 'not clever'
-
ILO financial crisis takes centre stage in leadership race
-
Weinstein resentenced to 15 years in prison for 2006 sex assault
-
Stocks dip, oil soars despite Trump hailing "productive" Iran talks
-
Fendi brings disco bling, Italian style, to Milan Fashion Week
-
China's Xi to get rare airport welcome from Trump
-
French court confirms rape trial for PSG and Morocco star Hakimi
-
Turkey reassures investors over investment fund crisis
-
President tells Trump that Iran will never 'bend at the knee'
-
Saka says England still have 'scar' from World Cup semi-final loss
-
أليكس بودي والبروفيسور الدكتور شتيفان هاوبت يتفقان على التعاون من أجل مجموعة فنية أسطورية في رومانيا
-
アレックス・ボディ氏とシュテファン・ハウプト教授、ルーマニアの伝説的な美術コレクションをめぐり提携に合意
-
U2 at 50: Irish rockers reveal anniversary album
-
亞歷克斯·博迪與史蒂芬·豪普特教授就羅馬尼亞傳奇藝術收藏達成合作協議
-
Алекс Боді та проф. д-р Стефан Гаупт домовилися про співпрацю щодо легендарної колекції мистецтва в Румунії
-
Алекс Боди и проф. д-р Стефан Хаупт договорились о сотрудничестве в рамках легендарной коллекции произведений искусства в Румынии
-
Alex Bodi și prof. dr. Stefan Haupt încheie un acord de cooperare pentru o colecție de artă legendară în România
-
French foreign minister says Palestinians 'must' hold polls
-
Alex Bodi and Prof. Dr Stefan Haupt agree to collaborate on a legendary art collection in Romania
-
Fresh Russian strikes on Ukraine's infrastructure kill seven
-
Stocks dip, oil rises as traders eye chances of Iran deal
-
Eriksen to return to Denmark after parting ways with Wolfsburg
-
Israel squeezing UN Palestinian refugee agency ahead of polls: chief
-
Brad Pitt says working with dog co-star was 'really moving'
-
Dutch to resume Eurovision with new broadcaster
-
Golan will remain Syrian, vows President al-Sharaa at UN
-
Man Utd losses jump despite record revenues
-
Blueberry Strengthens MENA Presence with CMA Category 5 License and Dubai Office Launch
-
Ethiopia's Tigray rebels seize airports, clash with govt forces
-
Russia probes bear attacks, as official says town under 'siege'
-
China prodigy wins third Games gold as North Korea weightlifters roar
-
Robertson tells Spurs to 'forget' past woes
-
China's Yu, 13, wins third Asian Games gold but has 'some regrets'
-
Italy police find 3 million euros stashed in mobster's house
-
Oil falls, stocks steady as Trump hails 'good' Iran talks
-
Renard versus Queiroz in AFCON qualifying blockbuster
-
UK sets up unit to combat disinformation from Russia, AI
-
Former Mexico boss Aguirre returns to Spain with Valencia
-
ICC convicts C.Africa rebel leader
-
China swimmer, 13, seals Games hat-trick as North Korea win first gold
-
China's Yu, 13, wins third gold with latest Asian Games record
-
China's Xi heads to US for talks with Trump: state media
-
UK says will revisit Chagos deal after latest Trump criticism
-
Azerbaijan pardons Frenchman after EU lifts sanctions on oligarchs
-
In first, French presidential candidate gives birth during campaign
-
Hadjar extends Red Bull contract for 2027 F1 season
-
Cambodia no 'safe haven' for cyberscams, PM says
Mercury Publishes Global Cold Chain Logistics Performance Benchmarks
Mercury publishes global cold chain logistics performance benchmarks for healthcare and life sciences shippers, covering transit times, reach, and reliability.
BOSTON, MA / ACCESS Newswire / July 30, 2026 / Mercury Business Services, a specialty logistics provider serving the healthcare and life sciences sector since 1984, today released performance benchmarks from its cold chain and parcel operations, reporting a 99.6% success rate on temperature-controlled shipments and a median cold chain transit time of 2.77 days.
The company also reported that customers using the Mercury Portal - its booking, tracking, and proactive monitoring platform - experienced a 39.7% reduction in parcel incidents compared to shipments managed outside the platform.
For laboratories, clinical trial sponsors, and diagnostics companies, a single compromised shipment can mean lost patient samples, delayed study timelines, and irreplaceable research material. Biological specimens, cell and gene therapy products, and diagnostic kits often have narrow stability windows and no second chance at collection.
Benchmark Highlights
99.6% successful cold chain shipments
2.77 days median cold chain transit time
39.7% reduction in parcel incidents for Mercury Portal users
236+ countries and territories served
1,500+ customers served since 2020
40+ years of continuous operation
Mercury attributes the results to a combination of proactive shipment monitoring, healthcare-specific customs brokerage that anticipates country-level documentation requirements before goods move, and 24/7 support teams assigned to individual accounts.
The company's services span specialty cold chain, discounted parcel, same-day and onboard courier, next flight out, air freight and charter, GMP warehousing and controlled room temperature storage, and customs brokerage. Mercury supports biological specimens, clinical trial materials, pre-clinical research, diagnostic testing kits, pharmaceuticals, medical devices, and regulated documents and records.
About Mercury Business Services
Founded in 1984, Mercury is a logistics provider built specifically for healthcare and life sciences shippers. Mercury delivers hundreds of thousands of shipments each year across 236+ countries and territories, combining a proprietary shipment management portal with dedicated client support teams. The company operates on three principles: Customers First, Relentless Improvement, and Extreme Ownership.
Media Contact
Organization: Mercury Business Services
Contact Person Name: Christian Gladwell
Website: https://www.shipmercury.com/
Email: [email protected]
Address: 61 Batterymarch St 1st Floor
City: Boston
State: MA
Country: United States
SOURCE: Mercury Business Services
View the original press release on ACCESS Newswire
L.Adams--AT